Loading organization details...
Loading organization details...
Source: IRS e-Filed Form 990 (from the IRS e-File system), Tax Year 2024
Total Revenue
▼$92.1M
Program Spending
80%
of total expenses go to program services
Total Contributions
$87.5M
Total Expenses
▼$94.8M
Total Assets
$42.5M
Total Liabilities
▼$31M
Net Assets
$11.5M
Officer Compensation
→$982.4K
Other Salaries
N/A
Investment Income
$687.7K
Fundraising
▼N/A
Source: USAspending.gov · Searched by organization name
Total Federal Funding
$675.5M
Awards Found
19
| Awarding Agency | Description | Amount | Fiscal Year | Period |
|---|---|---|---|---|
| Department of Health and Human Services | PROGRAMMATIC IMPLEMENTATION AND TECHNICAL ASSISTANCE (TA) FOR HIV/AIDS AN | $293.4M | FY2016 | Sep 2016 – Sep 2022 |
| Department of Health and Human Services | MAKWANDE ? GROWING SUSTAINABLE HIV/TB EPIDEMIC CONTROL IN SA - MAKWANDE - GROWING SUSTAINABLE HIV/TB EPIDEMIC CONTROL IN SA | $90.5M | FY2021 | Sep 2021 – Sep 2026 |
| Department of Health and Human Services | SUSTAINABLE HEALTH SYSTEMS STRENGTHENING THROUGH FACILITY-BASED TECHNICAL SUPPORT | $77.9M | FY2012 | Sep 2012 – Mar 2017 |
| Department of Health and Human Services | STRENGTHENING WORKPLACE INTERVENTIONS IN SMME'S IN SOUTH AFRICA | $72.6M | FY2007 | Sep 2007 – Sep 2013 |
| Department of Health and Human Services | STAFFING OF KEY DISTRICTS IN SOUTH AFRICA - A PARTNERSHIP BETWEEEN THE AURUM INST | $55.9M | FY2011 | Sep 2011 – Sep 2016 |
| Department of Health and Human Services | DCS ADMINISTRATIIVE REGIONS SOUTH AFRICA: GAUTENG, KWAZULA | $21.9M | FY2014 | Apr 2014 – Mar 2019 |
| Department of Health and Human Services | SILAPHA: RESPECTFUL, RELIABLE AND RESPONSIVE SERVICES FOR KEY POPULATIONS BY KEY POPULATIONS | $16.9M | FY2021 | Sep 2021 – Sep 2026 |
| Department of Health and Human Services | INTER-AGENCY PEPFAR ANNUAL PROGRAM STATEMENT US GOV'T MISSION TO SA | $13M | FY2004 | Sep 2004 – Aug 2009 |
| Agency for International Development | ACCELERATE TB ELIMINATION AND PROGRAM RESILIENCE ACTIVITY-HIGH BURDEN AREAS (ACCELERATE 1) | $11.2M | FY2023 | Sep 2023 – Aug 2028 |
| Department of Health and Human Services | GH13-1336, S. AFRICA: DCS ADMINISTRATIIVE REGIONS SOUTH AFRICA: GAUTENG, KWAZULA | $8.4M | FY2014 | Apr 2014 – Mar 2020 |
| Department of Health and Human Services | AURUM CLINICAL TRIALS UNIT - PROJECT SUMMARY SOUTHERN AND EAST AFRICA IS HOME TO 54% OF THE WORLD’S PEOPLE LIVING WITH HIV, WITH SOUTHERN AFRICA REMAINING AS THE EPICENTER OF THE GLOBAL HIV PANDEMIC. THE PROPOSED AURUM SOUTH AND EAST AFRICAN CLINICAL TRIALS UNIT (ASEA CTU) BRINGS TOGETHER A UNIQUE SOUTH–SOUTH PARTNERSHIP LED BY THREE INTERNATIONALLY RECOGNIZED INVESTIGATORS AND INCLUDING FIVE CLINICAL RESEARCH SITES (CRSS) (THREE IN SOUTH AFRICA, ONE IN ZAMBIA, AND ONE IN UGANDA) EXPERIENCED IN CONDUCTING HIV AND TB TREATMENT AND PREVENTION TRIALS. THE ASEA CTU HAS A STRONG CENTRALIZED MANAGEMENT STRUCTURE, WELL-DEVELOPED CRSS, ACCESS TO THE REQUIRED STUDY POPULATIONS, AND EXPERIENCE CONDUCTING HIV AND TB TREATMENT AND PREVENTION TRIALS. WHILE THERE HAVE BEEN ADVANCES IN TREATING AND PREVENTING HIV AND TB, WE NEED TO DEVELOP NEW TREATMENT AND PREVENTION TOOLS TO CONTROL HIV AND END THE TB EPIDEMIC. THE ASEA CTU’S PRIMARY GOAL IS TO USE ITS COLLECTIVE SCIENTIFIC LEADERSHIP, INFRASTRUCTURE, EXPERIENCE, AND STRONG COMMUNITY RELATIONSHIPS TO PARTNER WITH THREE NETWORKS TO MEET THE FOLLOWING AIMS: AIM 1: CONDUCT TRIALS OF HIV VACCINES AND ANTIBODIES FOR HIV PREVENTION. WE NEED A SAFE, EFFECTIVE HIV VACCINE THAT CAN BE DELIVERED AT SCALE TO COMBAT HIV; ANTIBODIES THAT COULD BE DELIVERED THROUGH PASSIVE INFUSION OR INDUCED BY VACCINATION WOULD COMPLEMENT TAKING ANTIRETROVIRAL THERAPY (ART) BEFORE POSSIBLE HIV EXPOSURE TO PREVENT BECOMING INFECTED WITH HIV. AIM 2: CONDUCT TRIALS OF HIV AND TB THERAPEUTICS, AND TB PREVENTIVE THERAPY AND VACCINES. IN ORDER TO END THE TB EPIDEMIC, WE NEED SHORTER, MORE POTENT COMBINATIONS OF DRUGS TO TREAT TB DISEASE OR INFECTION THAT IS SUSCEPTIBLE OR RESISTANT TO THE CURRENTLY AVAILABLE TB DRUGS, AND EFFECTIVE VACCINES TO PREVENT DISEASE OR RE-OCCURRENCE OF TB ONCE TREATED. DESPITE GREAT ADVANCES IN THE TREATMENT OF HIV, ADHERENCE TO AND RETENTION IN CARE REMAIN PROBLEMS; WE NEED NEW, SAFE, SIMPLE, EFFECTIVE, AND LONG-LASTING FORMS OF ART THAT WILL PROMOTE UPTAKE AND ADDRESS ADHERENCE CHALLENGES. AIM 3: PARTICIPATE IN STUDIES OF NOVEL LONG ACTING ANTIRETROVIRALS, MULTIPURPOSE TECHNOLOGIES, AND INTEGRATED STRATEGIES FOR HIV PREVENTION. OUR EXPERIENCE SUGGESTS THAT MORE TARGETED AND INDIVIDUALLY TAILORED INTERVENTIONS ARE REQUIRED TO OVERCOME ADHERENCE CHALLENGES WITH EXISTING PREVENTION OPTIONS. RATES OF SEXUALLY TRANSMITTED INFECTIONS (STIS) AND UNPLANNED PREGNANCY REMAIN HIGH AND UNDERSCORES THE NEED FOR TECHNOLOGIES THAT CAN PREVENT HIV AND OTHER CONDITIONS AT THE SAME TIME, SUCH AS STIS AND PREGNANCY. | $8.1M | FY2021 | Dec 2020 – Nov 2027 |
| Agency for International Development | APP - AAD 936-3090 | $2.6M | FY2012 | Jul 2012 – Jul 2016 |
| Department of Health and Human Services | GH11-1110, S. AFRICA: STAFFING OF KEY DISTRICTS IN SOUTH AFRICA - A PARTNERSHIP BETWEEEN THE AURUM INST | $1.3M | FY2011 | Sep 2011 – Sep 2017 |
| Department of Health and Human Services | AN IMPLEMENTATION SCIENCE STUDY INVESTIGATING PROFILES OF MEN INTERESTED IN MEDICAL MALE CIRCUMCISION (MMC), BARRIERS AND METHODS TO INCREASE THE UPT | $906K | FY2013 | Jul 2013 – Jun 2016 |
| Department of Health and Human Services | CONTINUITY OF TB AND HIV TREATMENT AMONG INMATES AFTER RELEASE FROM PRISON IN SOU | $719K | FY2012 | Jun 2012 – May 2017 |
| Department of Health and Human Services | FEASIBILITY AND ACCEPTABILITY OF A MHEALTH-INTERVENTION TO FIND AND LINK TB CASES TO CARE | $243.9K | FY2014 | Sep 2014 – Apr 2017 |
| Department of Health and Human Services | MOLEMOLEMO: BUILDING RESEARCH ADMINISTRATION EXCELLENCE IN SOUTH AFRICA - PROJECT SUMMARY THE GROWTH OF RESEARCH ACTIVITIES AT THE AURUM INSTITUTE (AURUM) IN JOHANNESBURG, SOUTH AFRICA, AND ITS OBJECTIVE TO ENGAGE IN MORE PRIMARY RESEARCH AWARDS ON THE AFRICAN CONTINENT, HAVE HIGHLIGHTED THE DESIRE FOR IMPROVED ADMINISTRATIVE OVERSIGHT OF NIH/NIAID GRANT AWARDS AND COMPLIANCE WITH NIH FUNDING POLICIES. TO ACHIEVE THE AIMS OUTLINED IN THIS APPLICATION, WE WILL WORK TOGETHER WITH VANDERBILT UNIVERSITY MEDICAL CENTER (VUMC) TO RECEIVE ADVANCED GRANTS ADMINISTRATION TRAINING AND EXPOSURE TO BEST BUSINESS PRACTICES. VUMC WILL ASSIST IN PERFORMING A MIXED METHODS NEEDS ASSESSMENT OF THE RESEARCH ADMINISTRATION AND MANAGEMENT ENVIRONMENT AT AURUM AND GENERATE AN ACTION PLAN THAT WILL IDENTIFY TRAINING NEEDS, PRIORITIZE PROCESSES, AND GUIDE PROGRAM IMPLEMENTATION. VUMC WILL LEAD VIRTUAL TRAINING WORKSHOPS ON A VARIETY OF ADMINISTRATIVE TOPICS AND WILL HOST A GRANTS MANAGEMENT PRACTICUM TO BE ATTENDED BY THE TWO PIS. A MAJOR FOCUS AND OUTPUT OF THE COLLABORATION WITH VUMC IS THE IN-HOUSE DEVELOPMENT OF A STRUCTURED GRANTS MANAGEMENT TRAINING COURSE FOR NON-US-BASED ORGANIZATIONS, TO BE COMPRISED OF ESSENTIAL AND ELECTIVE MODULES. THIS WILL BE THE VEHICLE THROUGH WHICH WE WILL ENSURE LASTING IMPACT OF THE TRAINING SUPPORT OFFERED THROUGH THIS GRANT. WITH TECHNICAL ASSISTANCE AND COURSE MATERIALS FROM VANDERBILT, THIS PROGRAM WILL BE DEVELOPED TO ENHANCE AND IMPROVE TRAINING IN GRANTS MANAGEMENT AND RESEARCH ADMINISTRATION. IN THE SECOND YEAR OF THE PRACTICUM AT VANDERBILT, AURUM ADMINISTRATORS WILL CREATE VIDEO TRAINING MODULES, WHICH WILL BE INSTRUMENTAL IN ROLLING OUT A STANDARDIZED GRANTS MANAGEMENT TRAINING PROGRAM ACROSS THE DIFFERENT AURUM ENTITIES IN SOUTH AFRICA AND ELSEWHERE IN AFRICA. IN ADDITION TO RECORDED MODULES, THE AURUM GRANTS MANAGEMENT TEAM WILL REGULARLY, AT A MINIMUM TWICE A YEAR, LEAD BOTH VIRTUAL AND IN-PERSON CLASSROOM TRAINING WORKSHOPS PER THE DEVELOPED TRAINING CURRICULUM ON A VARIETY OF ADMINISTRATIVE TOPICS RANGING FROM PROPOSAL DEVELOPMENT THROUGH AWARD CLOSEOUT. THE APPLICABLE MANDATORY MODULES WILL BECOME PART OF THE ON-BOARDING PROGRAM FOR NEW STAFF AND WE WILL CONTINUE TO DEVELOP AND UPDATE THE TRAINING COURSE AS AND WHEN NEEDED. THE PROPOSED DEVELOPMENT AWARD WILL ENABLE THE CREATION OF A HIGH-QUALITY RESEARCH ADMINISTRATION ENVIRONMENT AT THE AURUM INSTITUTE, ITS AFFILIATES, AND COLLABORATING PARTNERS, THAT IS KNOWLEDGEABLE AND COMPLIANT WITH THE FISCAL AND MANAGEMENT STANDARDS OF SPONSORED RESEARCH. | $105K | FY2022 | Apr 2022 – Jun 2024 |
| Department of Health and Human Services | GH12-1257, S. AFRICA: SUSTAINABLE HEALTH SYSTEMS STRENGTHENING THROUGH FACILITY-BASED TECHNICAL SUPPORT | -$1,876 | FY2012 | Sep 2012 – Sep 2018 |
| Department of Health and Human Services | STRENGTHENING WORKPLACE INTERVENTIONS IN SMME'S IN SOUTH AFRICA | -$135.5K | FY2007 | Sep 2007 – Sep 2014 |
Department of Health and Human Services
$293.4M
PROGRAMMATIC IMPLEMENTATION AND TECHNICAL ASSISTANCE (TA) FOR HIV/AIDS AN
Department of Health and Human Services
$90.5M
MAKWANDE ? GROWING SUSTAINABLE HIV/TB EPIDEMIC CONTROL IN SA - MAKWANDE - GROWING SUSTAINABLE HIV/TB EPIDEMIC CONTROL IN SA
Department of Health and Human Services
$77.9M
SUSTAINABLE HEALTH SYSTEMS STRENGTHENING THROUGH FACILITY-BASED TECHNICAL SUPPORT
Department of Health and Human Services
$72.6M
STRENGTHENING WORKPLACE INTERVENTIONS IN SMME'S IN SOUTH AFRICA
Department of Health and Human Services
$55.9M
STAFFING OF KEY DISTRICTS IN SOUTH AFRICA - A PARTNERSHIP BETWEEEN THE AURUM INST
Department of Health and Human Services
$21.9M
DCS ADMINISTRATIIVE REGIONS SOUTH AFRICA: GAUTENG, KWAZULA
Department of Health and Human Services
$16.9M
SILAPHA: RESPECTFUL, RELIABLE AND RESPONSIVE SERVICES FOR KEY POPULATIONS BY KEY POPULATIONS
Department of Health and Human Services
$13M
INTER-AGENCY PEPFAR ANNUAL PROGRAM STATEMENT US GOV'T MISSION TO SA
Agency for International Development
$11.2M
ACCELERATE TB ELIMINATION AND PROGRAM RESILIENCE ACTIVITY-HIGH BURDEN AREAS (ACCELERATE 1)
Department of Health and Human Services
$8.4M
GH13-1336, S. AFRICA: DCS ADMINISTRATIIVE REGIONS SOUTH AFRICA: GAUTENG, KWAZULA
Department of Health and Human Services
$8.1M
AURUM CLINICAL TRIALS UNIT - PROJECT SUMMARY SOUTHERN AND EAST AFRICA IS HOME TO 54% OF THE WORLD’S PEOPLE LIVING WITH HIV, WITH SOUTHERN AFRICA REMAINING AS THE EPICENTER OF THE GLOBAL HIV PANDEMIC. THE PROPOSED AURUM SOUTH AND EAST AFRICAN CLINICAL TRIALS UNIT (ASEA CTU) BRINGS TOGETHER A UNIQUE SOUTH–SOUTH PARTNERSHIP LED BY THREE INTERNATIONALLY RECOGNIZED INVESTIGATORS AND INCLUDING FIVE CLINICAL RESEARCH SITES (CRSS) (THREE IN SOUTH AFRICA, ONE IN ZAMBIA, AND ONE IN UGANDA) EXPERIENCED IN CONDUCTING HIV AND TB TREATMENT AND PREVENTION TRIALS. THE ASEA CTU HAS A STRONG CENTRALIZED MANAGEMENT STRUCTURE, WELL-DEVELOPED CRSS, ACCESS TO THE REQUIRED STUDY POPULATIONS, AND EXPERIENCE CONDUCTING HIV AND TB TREATMENT AND PREVENTION TRIALS. WHILE THERE HAVE BEEN ADVANCES IN TREATING AND PREVENTING HIV AND TB, WE NEED TO DEVELOP NEW TREATMENT AND PREVENTION TOOLS TO CONTROL HIV AND END THE TB EPIDEMIC. THE ASEA CTU’S PRIMARY GOAL IS TO USE ITS COLLECTIVE SCIENTIFIC LEADERSHIP, INFRASTRUCTURE, EXPERIENCE, AND STRONG COMMUNITY RELATIONSHIPS TO PARTNER WITH THREE NETWORKS TO MEET THE FOLLOWING AIMS: AIM 1: CONDUCT TRIALS OF HIV VACCINES AND ANTIBODIES FOR HIV PREVENTION. WE NEED A SAFE, EFFECTIVE HIV VACCINE THAT CAN BE DELIVERED AT SCALE TO COMBAT HIV; ANTIBODIES THAT COULD BE DELIVERED THROUGH PASSIVE INFUSION OR INDUCED BY VACCINATION WOULD COMPLEMENT TAKING ANTIRETROVIRAL THERAPY (ART) BEFORE POSSIBLE HIV EXPOSURE TO PREVENT BECOMING INFECTED WITH HIV. AIM 2: CONDUCT TRIALS OF HIV AND TB THERAPEUTICS, AND TB PREVENTIVE THERAPY AND VACCINES. IN ORDER TO END THE TB EPIDEMIC, WE NEED SHORTER, MORE POTENT COMBINATIONS OF DRUGS TO TREAT TB DISEASE OR INFECTION THAT IS SUSCEPTIBLE OR RESISTANT TO THE CURRENTLY AVAILABLE TB DRUGS, AND EFFECTIVE VACCINES TO PREVENT DISEASE OR RE-OCCURRENCE OF TB ONCE TREATED. DESPITE GREAT ADVANCES IN THE TREATMENT OF HIV, ADHERENCE TO AND RETENTION IN CARE REMAIN PROBLEMS; WE NEED NEW, SAFE, SIMPLE, EFFECTIVE, AND LONG-LASTING FORMS OF ART THAT WILL PROMOTE UPTAKE AND ADDRESS ADHERENCE CHALLENGES. AIM 3: PARTICIPATE IN STUDIES OF NOVEL LONG ACTING ANTIRETROVIRALS, MULTIPURPOSE TECHNOLOGIES, AND INTEGRATED STRATEGIES FOR HIV PREVENTION. OUR EXPERIENCE SUGGESTS THAT MORE TARGETED AND INDIVIDUALLY TAILORED INTERVENTIONS ARE REQUIRED TO OVERCOME ADHERENCE CHALLENGES WITH EXISTING PREVENTION OPTIONS. RATES OF SEXUALLY TRANSMITTED INFECTIONS (STIS) AND UNPLANNED PREGNANCY REMAIN HIGH AND UNDERSCORES THE NEED FOR TECHNOLOGIES THAT CAN PREVENT HIV AND OTHER CONDITIONS AT THE SAME TIME, SUCH AS STIS AND PREGNANCY.
Agency for International Development
$2.6M
APP - AAD 936-3090
Department of Health and Human Services
$1.3M
GH11-1110, S. AFRICA: STAFFING OF KEY DISTRICTS IN SOUTH AFRICA - A PARTNERSHIP BETWEEEN THE AURUM INST
Department of Health and Human Services
$906K
AN IMPLEMENTATION SCIENCE STUDY INVESTIGATING PROFILES OF MEN INTERESTED IN MEDICAL MALE CIRCUMCISION (MMC), BARRIERS AND METHODS TO INCREASE THE UPT
Department of Health and Human Services
$719K
CONTINUITY OF TB AND HIV TREATMENT AMONG INMATES AFTER RELEASE FROM PRISON IN SOU
Department of Health and Human Services
$243.9K
FEASIBILITY AND ACCEPTABILITY OF A MHEALTH-INTERVENTION TO FIND AND LINK TB CASES TO CARE
Department of Health and Human Services
$105K
MOLEMOLEMO: BUILDING RESEARCH ADMINISTRATION EXCELLENCE IN SOUTH AFRICA - PROJECT SUMMARY THE GROWTH OF RESEARCH ACTIVITIES AT THE AURUM INSTITUTE (AURUM) IN JOHANNESBURG, SOUTH AFRICA, AND ITS OBJECTIVE TO ENGAGE IN MORE PRIMARY RESEARCH AWARDS ON THE AFRICAN CONTINENT, HAVE HIGHLIGHTED THE DESIRE FOR IMPROVED ADMINISTRATIVE OVERSIGHT OF NIH/NIAID GRANT AWARDS AND COMPLIANCE WITH NIH FUNDING POLICIES. TO ACHIEVE THE AIMS OUTLINED IN THIS APPLICATION, WE WILL WORK TOGETHER WITH VANDERBILT UNIVERSITY MEDICAL CENTER (VUMC) TO RECEIVE ADVANCED GRANTS ADMINISTRATION TRAINING AND EXPOSURE TO BEST BUSINESS PRACTICES. VUMC WILL ASSIST IN PERFORMING A MIXED METHODS NEEDS ASSESSMENT OF THE RESEARCH ADMINISTRATION AND MANAGEMENT ENVIRONMENT AT AURUM AND GENERATE AN ACTION PLAN THAT WILL IDENTIFY TRAINING NEEDS, PRIORITIZE PROCESSES, AND GUIDE PROGRAM IMPLEMENTATION. VUMC WILL LEAD VIRTUAL TRAINING WORKSHOPS ON A VARIETY OF ADMINISTRATIVE TOPICS AND WILL HOST A GRANTS MANAGEMENT PRACTICUM TO BE ATTENDED BY THE TWO PIS. A MAJOR FOCUS AND OUTPUT OF THE COLLABORATION WITH VUMC IS THE IN-HOUSE DEVELOPMENT OF A STRUCTURED GRANTS MANAGEMENT TRAINING COURSE FOR NON-US-BASED ORGANIZATIONS, TO BE COMPRISED OF ESSENTIAL AND ELECTIVE MODULES. THIS WILL BE THE VEHICLE THROUGH WHICH WE WILL ENSURE LASTING IMPACT OF THE TRAINING SUPPORT OFFERED THROUGH THIS GRANT. WITH TECHNICAL ASSISTANCE AND COURSE MATERIALS FROM VANDERBILT, THIS PROGRAM WILL BE DEVELOPED TO ENHANCE AND IMPROVE TRAINING IN GRANTS MANAGEMENT AND RESEARCH ADMINISTRATION. IN THE SECOND YEAR OF THE PRACTICUM AT VANDERBILT, AURUM ADMINISTRATORS WILL CREATE VIDEO TRAINING MODULES, WHICH WILL BE INSTRUMENTAL IN ROLLING OUT A STANDARDIZED GRANTS MANAGEMENT TRAINING PROGRAM ACROSS THE DIFFERENT AURUM ENTITIES IN SOUTH AFRICA AND ELSEWHERE IN AFRICA. IN ADDITION TO RECORDED MODULES, THE AURUM GRANTS MANAGEMENT TEAM WILL REGULARLY, AT A MINIMUM TWICE A YEAR, LEAD BOTH VIRTUAL AND IN-PERSON CLASSROOM TRAINING WORKSHOPS PER THE DEVELOPED TRAINING CURRICULUM ON A VARIETY OF ADMINISTRATIVE TOPICS RANGING FROM PROPOSAL DEVELOPMENT THROUGH AWARD CLOSEOUT. THE APPLICABLE MANDATORY MODULES WILL BECOME PART OF THE ON-BOARDING PROGRAM FOR NEW STAFF AND WE WILL CONTINUE TO DEVELOP AND UPDATE THE TRAINING COURSE AS AND WHEN NEEDED. THE PROPOSED DEVELOPMENT AWARD WILL ENABLE THE CREATION OF A HIGH-QUALITY RESEARCH ADMINISTRATION ENVIRONMENT AT THE AURUM INSTITUTE, ITS AFFILIATES, AND COLLABORATING PARTNERS, THAT IS KNOWLEDGEABLE AND COMPLIANT WITH THE FISCAL AND MANAGEMENT STANDARDS OF SPONSORED RESEARCH.
Department of Health and Human Services
-$1,876
GH12-1257, S. AFRICA: SUSTAINABLE HEALTH SYSTEMS STRENGTHENING THROUGH FACILITY-BASED TECHNICAL SUPPORT
Department of Health and Human Services
-$135.5K
STRENGTHENING WORKPLACE INTERVENTIONS IN SMME'S IN SOUTH AFRICA
Source: Federal Audit Clearinghouse (fac.gov)
No federal single audit records found for this organization.
Single audits are required for entities expending $750,000+ in federal awards annually.
Tax Year 2024 · Source: IRS e-Filed Form 990
Individuals serving as officers, directors, or trustees of the organization.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other |
|---|
Source: IRS Publication 78, Auto-Revocation List & e-Postcard Data
Tax-deductible contributions: Not confirmed
No additional tax-exempt status records found in ReconForce's database.
Sources: IRS e-Filed Form 990 (XML) & ProPublica Nonprofit Explorer
Scroll →
| Year | Revenue | Contributions | Expenses | Assets | Net Assets |
|---|---|---|---|---|---|
| 2024IRS e-File | $92.1M | $87.5M | $94.8M | $42.5M | $11.5M |
| 2023 | $75.2M | $70.2M | $78.7M | $41.7M | $10.2M |
Sources: ProPublica Nonprofit Explorer & IRS e-File Index
| Tax Year | Form Type | Source | Documents |
|---|---|---|---|
| 2024 | 990 | IRS e-File | PDF not yet published by IRSView Filing → |
| 2023 | 990 | DataIRS e-File | PDF not yet published by IRSView Filing → |
Financial data: IRS e-Filed Form 990 (Tax Year 2024)
Leadership & compensation: IRS e-Filed Form 990, Part VII (Tax Year 2024)
Federal grants: USAspending.gov (live)
Organization info: IRS Business Master File
| Total |
|---|
| Gavin Churchyard | Chief Executive Officer | 40 | $411.4K | $0 | $0 | $411.4K |
| Dr David Alan Clark | Group Chief Operating Officer | 40 | $245.6K | $0 | $0 | $245.6K |
| Arshad Hassim | Chief Financial Officer | 40 | $218.2K | $0 | $0 | $218.2K |
| Dr Jeremia Majaheni Gule | Board Chair | 2 | $26K | $0 | $0 | $26K |
Gavin Churchyard
Chief Executive Officer
$411.4K
Hrs/Wk
40
Compensation
$411.4K
Related Orgs
$0
Other
$0
Dr David Alan Clark
Group Chief Operating Officer
$245.6K
Hrs/Wk
40
Compensation
$245.6K
Related Orgs
$0
Other
$0
Arshad Hassim
Chief Financial Officer
$218.2K
Hrs/Wk
40
Compensation
$218.2K
Related Orgs
$0
Other
$0
Dr Jeremia Majaheni Gule
Board Chair
$26K
Hrs/Wk
2
Compensation
$26K
Related Orgs
$0
Other
$0
Highest compensated employees who are not officers or directors.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other | Total |
|---|---|---|---|---|---|---|
| Dr Akinlolu Oluwafemi Fasanmi | Sr Clinical Data Manager | 40 | $532.8K | $0 | $0 | $532.8K |
| Dr Robert Wallis | Chief Scientific Officer | 10 | $0 | $482.1K | $0 | $482.1K |
| La Chenna Cromer | Dir. New Prog & Innovation | 40 | $295.9K | $0 | $0 | $295.9K |
| Salome Charalambous | Group Global Health Officer | 40 | $240.5K | $0 | $0 | $240.5K |
| Vinodh Aroon Edward | Chief Executive Officer Sa | 40 | $216.3K | $0 | $0 | $216.3K |
Dr Akinlolu Oluwafemi Fasanmi
Sr Clinical Data Manager
$532.8K
Hrs/Wk
40
Compensation
$532.8K
Related Orgs
$0
Other
$0
Dr Robert Wallis
Chief Scientific Officer
$482.1K
Hrs/Wk
10
Compensation
$0
Related Orgs
$482.1K
Other
$0
La Chenna Cromer
Dir. New Prog & Innovation
$295.9K
Hrs/Wk
40
Compensation
$295.9K
Related Orgs
$0
Other
$0
Members of the governing board. Board members often serve without compensation.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other | Total |
|---|---|---|---|---|---|---|
| Adv Louisa Barbara Zondo | Board Director | 1 | $4,818 | $0 | $0 | $4,818 |
| Alex Boama Darko | Board Director | 1 | $7,577 | $0 | $0 | $7,577 |
| Dr Letticia Moja | Board Director | 1 | $5,492 | $0 | $0 | $5,492 |
| Dr Maria Angelica Salomao | Board Director | 1 | $5,931 | $0 | $0 | $5,931 |
| Dr Yaw Oppong Peprah | Board Director | 1 | $7,577 | $0 | $0 | $7,577 |
| Gary Robert Tamblyn |
Adv Louisa Barbara Zondo
Board Director
$4,818
Hrs/Wk
1
Compensation
$4,818
Related Orgs
$0
Other
$0
Alex Boama Darko
Board Director
$7,577
Hrs/Wk
1
Compensation
$7,577
Related Orgs
$0
Other
$0
Dr Letticia Moja
Board Director
$5,492
Hrs/Wk
1
Compensation
$5,492
Related Orgs
$0
Other
$0
Salome Charalambous
Group Global Health Officer
$240.5K
Hrs/Wk
40
Compensation
$240.5K
Related Orgs
$0
Other
$0
Vinodh Aroon Edward
Chief Executive Officer Sa
$216.3K
Hrs/Wk
40
Compensation
$216.3K
Related Orgs
$0
Other
$0
| Board Director |
| 1 |
| $9,922 |
| $0 |
| $0 |
| $9,922 |
| Nigel William Unwin | Board Director | 1 | $12.1K | $0 | $0 | $12.1K |
| Paula Maria Fray | Board Director | 1 | $14.2K | $0 | $0 | $14.2K |
| Pontiano Nakugoba Kaleebu | Board Director | 1 | $3,202 | $0 | $0 | $3,202 |
| Xoli Sarah Luthuli | Board Director | 1 | $10.2K | $0 | $0 | $10.2K |
Dr Maria Angelica Salomao
Board Director
$5,931
Hrs/Wk
1
Compensation
$5,931
Related Orgs
$0
Other
$0
Dr Yaw Oppong Peprah
Board Director
$7,577
Hrs/Wk
1
Compensation
$7,577
Related Orgs
$0
Other
$0
Gary Robert Tamblyn
Board Director
$9,922
Hrs/Wk
1
Compensation
$9,922
Related Orgs
$0
Other
$0
Nigel William Unwin
Board Director
$12.1K
Hrs/Wk
1
Compensation
$12.1K
Related Orgs
$0
Other
$0
Paula Maria Fray
Board Director
$14.2K
Hrs/Wk
1
Compensation
$14.2K
Related Orgs
$0
Other
$0
Pontiano Nakugoba Kaleebu
Board Director
$3,202
Hrs/Wk
1
Compensation
$3,202
Related Orgs
$0
Other
$0
Xoli Sarah Luthuli
Board Director
$10.2K
Hrs/Wk
1
Compensation
$10.2K
Related Orgs
$0
Other
$0